PITTSFORD, NY--(Marketwire - April 08, 2008) - Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced that Myotech, the company’s majority-owned subsidiary, has entered into a Memorandum of Understanding with PPA Technologies to explore the potential for a strategic relationship regarding the development and commercialization of their respective technologies.
